Alpha Cancer Technologies Inc. (ACT) is a private clinical stage biotechnology company with platform technologies in Immunotherapy and Immuno-Oncology. These platforms under development treat auto-immune disease indications and cancer. The company’s drug products use our proprietary recombinant human alpha fetoprotein (AFP).
View Top Employees from Alpha Cancer Technologies Inc.| Website | http://www.alpha-cancer.com |
| Revenue | $5 million |
| Employees | 5 (2 on RocketReach) |
| Founded | 2008 |
| Address | MARS CENTER, SOUTH TOWER, 200-101 COLLEGE ST, Toronto, Ontario M5G 1L7, CA |
| Phone | (416) 826-6626 |
| Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Pharmaceutical, Health Care |
| Web Rank | 17 Million |
| Keywords | Alpha Cancer Technologies |
| Competitors | ATGCell Inc., Bold Therapeutics Inc., Nexelis, a Q² Solutions Company, Novelogics Biotechnology Inc., Qu Biologics Inc. |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies |
Looking for a particular Alpha Cancer Technologies Inc. employee's phone or email?
Alpha Cancer Technologies Inc. Questions
The Alpha Cancer Technologies Inc. annual revenue was $5 million in 2024.
2 people are employed at Alpha Cancer Technologies Inc..
Alpha Cancer Technologies Inc. is based in Toronto, Ontario.
The NAICS codes for Alpha Cancer Technologies Inc. are [541714, 5417, 541, 54, 54171].
The SIC codes for Alpha Cancer Technologies Inc. are [87, 873].
Top Alpha Cancer Technologies Inc. Employees
-
35+
-
45+
Related Companies
